80 related articles for article (PubMed ID: 10974877)
1. [Assessment of usefulness of PCNA and protein p53 in subjects with laryngeal cancer with local recurrence].
Morawski K; Gabriel A; Namysłowski G; Pietrawska V; Ziółkowski A; Urbaniec P
Otolaryngol Pol; 2000; 54 Suppl 31():174-7. PubMed ID: 10974877
[TBL] [Abstract][Full Text] [Related]
2. [Assessment of usefulness of PCNA and oncoprotein p53 staining in prediction of the recurrences in subjects operated on for laryngeal carcinoma].
Morawski K; Namysłowski G; Gabriel A; Pietrawska V; Ziółkowski A; Urbaniec P
Otolaryngol Pol; 2000; 54(4):393-9. PubMed ID: 11070693
[TBL] [Abstract][Full Text] [Related]
3. Clinical application of proliferating cell nuclear antigen, oncoprotein p53 and tumor front grading analysis in patients operated on for laryngeal cancer.
Morawski K; Gabriel A; Namyslowski G; Ziólkowski A; Pietrawska V; Steplewska K
Eur Arch Otorhinolaryngol; 1999; 256(8):378-83. PubMed ID: 10525938
[TBL] [Abstract][Full Text] [Related]
4. Ki-67 (MIB1), p53, and Lewis-X (LeuM1) as prognostic factors of recurrence in T1 and T2 laryngeal carcinoma.
Sittel C; Eckel HE; Damm M; von Pritzbuer E; Kvasnicka HM
Laryngoscope; 2000 Jun; 110(6):1012-7. PubMed ID: 10852523
[TBL] [Abstract][Full Text] [Related]
5. [Expression of p53, p21, PCNA and COX-2 and its relationship with recurrence in the early-stage laryngeal cancer with negative surgical margin].
Zeng R
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Mar; 30(5):349-52, 356. PubMed ID: 27382672
[TBL] [Abstract][Full Text] [Related]
6. PCNA--a cell proliferation marker in vocal cord cancer. Part II: Recurrence in malignant laryngeal lesions.
Broich G; Lavezzi AM; Biondo B; Pignataro LD
In Vivo; 1996; 10(2):175-8. PubMed ID: 8744797
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of expression of p53, proliferating cell nuclear antigen, and c-erbB-2 in laryngeal carcinoma.
Micozkadioğlu D; Unal M; Pata YS; Baştürk M; Cinel L
Med Sci Monit; 2008 Jun; 14(6):CR299-304. PubMed ID: 18509272
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical expression of metallothionein in benign premalignant and malignant epithelium of the larynx: correlation with p53 and proliferative cell nuclear antigen.
Ioachim E; Assimakopoulos D; Peschos D; Zissi A; Skevas A; Agnantis NJ
Pathol Res Pract; 1999; 195(12):809-14. PubMed ID: 10631715
[TBL] [Abstract][Full Text] [Related]
9. P53 and PCNA is positively correlated with HPV infection in laryngeal epitheliopapillomatous lesions in patiets with different ethnic backgrounds in Xinjiang.
Sun J; Xiong J; Zhen Y; Chen ZL; Zhang H
Asian Pac J Cancer Prev; 2012; 13(11):5439-44. PubMed ID: 23317197
[TBL] [Abstract][Full Text] [Related]
10. Changes in expression of p53, proliferating cell nuclear antigen and bcl-2 in recurrent laryngeal cancer after radiotherapy.
Lee BJ; Wang SG; Roh HJ; Goh EK; Chon KM; Park DY
J Laryngol Otol; 2006 Jul; 120(7):579-82. PubMed ID: 16672091
[TBL] [Abstract][Full Text] [Related]
11. [The effects on expressions of p53 and PCNA by inhibition of hTERT with siRNA in transplantable model of human laryngeal squamous carcinoma in nude mice].
Zhou J; Zhou X; Tao Z; Xiao B; Chen S; Liu D
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2006 Mar; 20(6):264-7. PubMed ID: 16739381
[TBL] [Abstract][Full Text] [Related]
12. Expression patterns of cyclins D1, E in laryngeal epithelial lesions: correlation with other cell cycle regulators (p53, pRb, Ki-67 and PCNA) and clinicopathological features.
Ioachim E; Peschos D; Goussia A; Mittari E; Charalabopoulos K; Michael M; Salmas M; Vougiouklakis T; Assimakopoulos D; Agnantis NJ
J Exp Clin Cancer Res; 2004 Jun; 23(2):277-83. PubMed ID: 15354413
[TBL] [Abstract][Full Text] [Related]
13. Prediction of occult neck metastases in laryngeal carcinoma: role of proliferating cell nuclear antigen, MIB-1, and E-cadherin immunohistochemical determination.
Franchi A; Gallo O; Boddi V; Santucci M
Clin Cancer Res; 1996 Oct; 2(10):1801-8. PubMed ID: 9816133
[TBL] [Abstract][Full Text] [Related]
14. Flow cytometric analysis and immunohistochemical staining for the p53 protein and proliferating cell nuclear antigen in submucosal carcinoma of the esophagus.
Kimura H; Konishi K; Maeda K; Yabushita K; Kuroda Y; Tsuji M; Miwa A
Hepatogastroenterology; 1999; 46(25):285-9. PubMed ID: 10228808
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of Ki-67 (MIB1), PCNA and p53 in cancer of the oropharynx and oral cavity.
Sittel C; Ruiz S; Volling P; Kvasnicka HM; Jungehülsing M; Eckel HE
Oral Oncol; 1999 Nov; 35(6):583-9. PubMed ID: 10705094
[TBL] [Abstract][Full Text] [Related]
16. [Expression of six gene proteins in laryngeal carcinomas and their significance].
Wu X; He S; Wu M; Zhou L
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2005 Jul; 19(14):648-51. PubMed ID: 16248464
[TBL] [Abstract][Full Text] [Related]
17. [Precancerous states of the larynx: analysis of mono- and polyclonality of the cells with high proliferative index (p53, PCNA)].
Gabriel A; Namysłowski G; Drozdzowska B; Morawski K; Steplewska-Mazur K; Gwóźdź M
Otolaryngol Pol; 2000; 54 Suppl 31():178-81. PubMed ID: 10974878
[TBL] [Abstract][Full Text] [Related]
18. Cell cycle proteins in laryngeal cancer: role in proliferation and prognosis.
Peschos D; Stefanou D; Vougiouklakis T; Assimakopoulos DA; Agnantis NJ
J Exp Clin Cancer Res; 2005 Sep; 24(3):431-7. PubMed ID: 16270530
[TBL] [Abstract][Full Text] [Related]
19. Expression form of p53 and PCNA at the invasive front in oral squamous cell carcinoma: correlation with clinicopathological features and prognosis.
Kato K; Kawashiri S; Yoshizawa K; Kitahara H; Okamune A; Sugiura S; Noguchi N; Yamamoto E
J Oral Pathol Med; 2011 Oct; 40(9):693-8. PubMed ID: 21501231
[TBL] [Abstract][Full Text] [Related]
20. The prognostic value of proliferating cell nuclear antigen (PCNA) and p53 protein expression in patients with advanced nasopharyngeal carcinoma.
Wang LF; Chai CY; Kuo WR; Tai CF; Lee KW; Ho KY
Acta Otolaryngol; 2006 Jul; 126(7):769-74. PubMed ID: 16803719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]